NOT-CA-17-073: Notice of Correction to RFA-CA-17-011 "Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)"

Notice of Correction to RFA-CA-17-011 "Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)"

Notice Number: NOT-CA-17-073

Key Dates
Release Date: July 6, 2017

Related Announcements
RFA-CA-17-011

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to add a correction to RFA-CA-17-011 "Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)".

Part 1. Overview Information

Currently reads:

Announcement Type: Reissue of RFA-CA-16-004

Modified to read (in italics)

Announcement Type: Reissue of RFA-CA-16-002

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Tony Dickherber, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-547-9980
Email: dickherberaj@mail.nih.gov

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov